Protein catabolism is recognized as an important physiological process in all cells. Many proteins are proteolytically modified to produce either a mature form or a form with altered activity. Specific cleavages of certain classes of proteins are associated with important cellular processes, such as response to DNA damage (6, 40, 42) , adaptation to starving conditions (29, 43) , and catabolism of abnormal proteins (4, (8) (9) (10) .
Proteolytic enzymes of membranes have been reported to play critical roles in such important processes as the processing of secretory and membrane proteins (5, 41) , utilization of exogenous peptides (25) , viral morphogenesis (28) , breakdown of colicins (2, 3) , and membrane biogenesis (14, 18) in Escherichia coli. The purification and characterization of two tnembrane enzymes (protease IV and protease V) have been reported by Pacaud (31, 32) . Protease IV is an inner membrane-associated protease, which was identified as a signal peptide peptidase by Ichihara et al. (17) . Protease V is localized at both inner and outer membranes and preferentially hydrolyzes L-glycine and L-phenylalanine derivatives. Palmer and St. John have reported the identification of an outer membrane-associated protease termed protease VI (33) . Protease VI is a serine protease and generates acid-soluble fragments from a mixture of E. coli membrane proteins. It may play a role in the turnover of E. coli membrane proteins, but its real physiological role has not been identified.
We have previously reported a novel outer membraneassociated protease in E. coli which we termed protease VII (39) . Protease VII was identified as a protease having unique substrate specificity for paired basic amino acid residues. Apparently, this enzyme had escaped detection by the yeast extracts were from Difco Laboratories, Detroit, MI. Recombinant human gamma interferon was produced in our laboratory. All other inhibitors, detergents, and electrophoresis reagents were obtained from Nakarai Chemicals, Ltd., Kyoto, Japan. Bacterial strains and culture conditions. The E. coli strains used were W3110 and JM109. For enzyme purification, W3110 cells were cultured in LB medium (24) at 37°C with shaking in 1-liter Erlenmeyer flasks, each containing 400 ml of medium.
Cell harvesting and membrane isolation. Cells were harvested by centrifugation at late logarithmic phase at an OD660 of about 2.0. After being washed with buffer A (50 mM Tris hydrochloride buffer, pH 7.5), 12.6 g of cells was suspended in 88 ml of the same buffer and disrupted by passage through a French pressure cell at 20,000 lb/in2. Unbroken cells were removed by centrifugation at 1,000 x g for 10 min, and the resultant supernatant was centrifuged at 36 ,000 x g for 40 min to collect the whole membrane fraction. The crude membrane fraction was suspended in 15 ml of buffer A and collected by centrifugation as above.
Enzyme purification. The membrane pellet was carefully suspended in 100 ml of buffer A containing 0.1% sarcosyl, and the suspension was shaken for 1 h at 10°C. After centrifugation at 36,000 x g for 40 min, the supernatant was removed and the pellet was reextracted with 110 ml of buffer A containing 0.1% Triton X-100 and 5 mM EDTA by shaking for 1 h at room temperature. After centrifugation at 36,000 x g for 40 min, the supernatant was removed and directly applied to a DEAE-Toyopearl column (25 by 150 mm) equilibrated with buffer B (50 mM Tris hydrochloride buffer [pH 7.5], containing 0.1% Triton X-100). The column was washed with 2 column volumes of the same buffer, and the adsorbed proteins were eluted by washing the column with a linear gradient of NaCl from 0 to 0.4 M in 640 ml of buffer B. The fractions containing protease VII activity, measured as described below, were pooled and dialyzed against buffer B. The dialyzed enzyme fraction was applied to a benzamidine-Sepharose 6B column (10 by 80 mm) equilibrated with buffer B. The column was washed with 4 column volumes of buffer B, and the adsorbed proteins were eluted with a linear NaCl concentration gradient, generated by mixing 40 ml of buffer B containing 0.3 M NaCl into an equal volume of buffer B. Fractions (3.2 ml) were collected. The fractions containing the activity were pooled and analyzed by PAGE and SDS-PAGE.
Enzyme assay. For the detection of protease VII activity in column eluates, we used recombinant human gamma interferon as a substrate. The cleavage of recombinant human gamma interferon was assayed by the method reported previously (39) . For the other experiments, we used dynorphin A (1-13) as a substrate. Appropriately diluted enzyme fraction (5 RI) was added to 40 RI of 50 mM sodium phosphate buffer, pH 6.0, containing 0.1% Triton X-100. The reaction was started by the addition of 5 ptu (5 Rg) of dynorphin A and incubated for 10 min at 250C. After the reaction was stopped by the addition of 5 RI of 1 N HCI, a portion was subjected to HPLC. A 20-,ul sample was applied to a column of YMC A-302 ODS (4.6 by 150 mm) (YMC Lab.
Co., Ltd.), and elution was carried out with a linear gradient of 16 to 40% CH3CN in 0.1% trifluoroacetic acid solution at a flow rate of 1 ml/min. The effluent was monitored by measuring the A210, and the amount of the degradation product Tyr-1-Gly-Gly-Phe-Leu-Arg-6 was estimated (39) . One unit of protease VII activity was defined as 1 pmol of dynorphin A cleaved per min. Hydrolysis of MCA substrates was assayed as follows.
Purified protease VII (0.1 pRg in 10 [lI of buffer B) was added to a reaction mixture containing 10 ,ug of a substrate in 1 ml of 50 mM sodium phosphate buffer, pH 6.0, at 25°C. The increase in the relative fluorescence with excitation at 380 nm and emission at 460 nm was monitored with a Hitachi F-4000 fluorescence spectrophotometer.
Hydrolysis of biologically active peptides and determination of digestion products were done as follows. Purified protease VII (0.1 pg in 10 RI of buffer B) was added to each reaction mixture containing 20 to 40 ,ug of substrate in 90 RI of 50 mM sodium phosphate buffer, pH 6.0, at 25°C for 30 min. After the reaction was stopped by the addition of 10 plA of 1 N HCI, the digested peptides were fractionated by HPLC. A sample (100 ,ul) was applied to a column of YMC A-302 ODS (4.6 by 150 mm), and elution was carried out with a linear gradient of 0 to 48% CH3CN in 0.1% trifluoroacetic acid solution at a flow rate of 1 ml/min. The effluent was monitored by measuring the A210. Digested products were collected, and their amino acid compositions were analyzed by an amino acid analyzer as described previously (39) .
The effects of various inhibitors and bivalent cations on protease VII activity were measured as follows. Protease VII (10 ng in 10 RI of buffer A) was added to 80 ,lI of the same buffer containing a protease inhibitor or cation. After incubation for 30 min at 25°C, 10 RI (10 ,ug) of dynorphin A was added, and incubation was continued for 10 min. Protease VII activity was determined as described above.
PAGE and molecular weight determinations. PAGE under nondenaturing condition was carried out on 7.5% gel with Triton X-100 instead of SDS by the method of Laemmli (21) . The molecular weight of SDS-denatured protease VII was estimated by electrophoresis in the presence of SDS, carried out on a 10% polyacrylamide gel with the Laemmli system (21) . The molecular weight markers, phosphorylase b (94,000), albumin (67,000), ovalbumin (43,000), carbonic anhydrase (30,000), trypsin inhibitor (20,100), and a-lactalbumin (14,400), were used for estimation (Pharmacia Fine Chemicals). The molecular weight of native protease VII was determined by gel permeation HPLC on a TSK G-3000SW column (7.5 by 600 mm) (Toyo Soda Mfg. Co., Ltd.). The column was equilibrated with 0.1 M potassium phosphate buffer, pH 6.0, containing 0.1% Triton X-100 and 0.2 M NaCl. Purified protease VII solution (benzamidine-Sepharose 6B effluent) was resolved on the column at a flow rate of 0.7 ml/min. Standard proteins used for molecular weight determination were glutamate dehydrogenase (290,000), lactate dehydrogenase (142,000), enolase (67,000), adenylate kinase (32,000), and cytochrome c (12,400) (Oriental Yeast Co., Ltd., Tokyo, Japan).
Protein determination. Protein concentration was measured by the method of Lowry et al. (23) with bovine serum albumin as a standard. The method of Bensadoun and Weinstein (1) was used when a sample contained Triton X-100 or EDTA.
Amino acid sequence analysis. Purified protease VII (100 ,ug) was dialyzed against distilled water and applied to an automatic gas-phase sequencer (Applied Biosystems).
Cloning and nucleotide sequence analysis. DNA isolation, restriction endonuclease digestion, ligation, transformation, and agarose gel electrophoresis were performed as described by Maniatis et al. (24) . Cloning of the gene encoding protease VII was reported previously (38) . From a library of W3110 genes cloned in EMBL3 phage, the protease VII gene was selected by complementation analysis of the protease VII- . The detergent-solubilized membrane proteins were applied to a DEAE-Toyopearl column (2.5 by 15 cm), and the chromatograph was developed as described in the text. Fractions (8.4 ml each) were collected at a flow rate of 2.1 ml/ min and analyzed for proteolytic activity against recombinant human gamma interferon. The active fractions were pooled, dialyzed against buffer B, and then applied to a benzamidine-Sepharose 6B column (1.0 by 8 cm). The chromatograph was developed as described in the text. Fractions (3.2 ml each) were collected at a flow rate of 0.8 ml/min and assayed for protease activity against recombinant human gamma interferon. Active fractions are indicated (+). Solid diagonal line, NaCl gradient. negative mutation, and plasmid pGP501, which carries a 1.75-kbp insert in the pUC19 vector, was subcloned (see Fig.  3 ). The 1.75-kbp insert was sequenced by the dideoxy chain termination method of Sanger et al. (36) with [k-32P]CTP for labeling and a 2-deoxy-7-deazaguanosine triphosphate sequencing kit (Takara Shuzo Co., Ltd.).
RESULTS
Purification of protease VII. Our preliminary study on the culture conditions required for the production of protease VII indicated that the intracellular protease VII activity in the cells increased about two-to threefold in the late logarithmic and stationary phases compared with that in the logarithmic phase. The protease VII activity in the cells cultured at 37°C was about 2.5-fold greater than it was at 300C. Accordingly, cultures were grown to the late logarithmic phase at 37°C for enzyme purification.
Solubilization of protease VII from membrane preparation was examined first. A 1% solution of cholic acid, deoxycholic acid, polyoxyethylene sorbitan monooleate (Tween 80), and Emulphogen BC720 could not solubilize the protease VII activity efficiently. A 0.1% solution of sarcosyl solubilized the membrane proteins well, but little protease VII activity was solubilized. A 0.1% solution of Triton X-100 solubilized about 30% of the total protease VII activity. The solubility of protease VII was increased by addition of the metal chelator EDTA. About half of the protease VII activity of total membranes was solubilized by 0.1% Triton X-100 plus 5 mM EDTA and about 90% by 1.0% Triton X-100 plus 5 mM EDTA. A high salt concentration could not solubilize protease VII activity. Taking these results into account, we devised a method for selective solubilization of protease VII by stepwise treatment with sarcosyl and Triton-EDTA as described in Materials and Methods. About 67% of the protease VII activity in the total membrane fraction was recovered, with an 11.3-fold increase in specific activity.
The detergent-solubilized membrane extracts were initially submitted to DEAE-Toyopearl column chromatography. Protease VII activity adsorbed to the column was eluted at an NaCl concentration of about 0.2 M (Fig. 1A) .
The pooled fraction showed one major band with a molecular weight of about 36,000 and three other minor bands on a 10% SDS-polyacrylamide gel. The specific activity of protease VII was increased about 1.5-fold through this step. The step was indispensable because the protein which could not be separated by the next benzamidine-Sepharose 6B column chromatography step could be removed by this step.
Further purification of protease VII was achieved by affinity chromatography on benzamidine-Sepharose 6B as described in Materials and Methods. Protease VII activity was eluted from the column at an NaCl concentration of about 0.15 M (Fig. 1B) . Fractions 10 to 15 were combined and subjected to analytical PAGE. Only one protein band was detected ( Fig. 2A) , showing that protease VII had been purified to homogeneity. A summary of the purification procedures for protease VII is given in Table 1 . These procedures led to a 24.3-fold purification of protease VII, with a recovery of 18.9% of the total activity originally present in whole membrane fractions.
Molecular weight. The molecular weight of protease VII was estimated by electrophoresis of purified protease VII in 10% SDS gel slabs. By comparison with the relative mobilities of protein standards, the molecular weight of protease VII was found to be 36,000 in the presence of SDS (Fig. 2B) . The enzyme was also subjected to analytical gel filtration A B through a TSK G-3000SW column as described in Materials and Methods. Protease VII emerged at a position corresponding to a molecular weight of 180,000 (data not illustrated).
Effect of pH on protease VII activity. The effect of pH on protease VII activity has been tested in a series of buffers for different pH values. The optimal pH for protease VII activity was 6.0 in 50 mM sodium phosphate buffer. Protease VII activity declined about 50% at pH 8.0 in buffer A. Inhibition of protease VII activity by 50 mM sodium acetate buffer was noted.
Effect of inhibitors and bivalent cations. The effects of protease inhibitors and metal chelators on the activity of protease VII were measured with dynorphin A as a substrate. The serine protease inhibitor DFP inactivated protease VII completely at a concentration of 5 mM but showed little effect at 0.5 mM. PMSF at 5 mM also inhibited protease VII a little. Tosyl-L-phenylalanine chloromethyl ketone, which alkylates the active site histidine residue of chymotrypsine, inhibited protease VII activity by 69% at a concentration of 1 mM. However, 1 mM tosyl-L-lysine chloromethyl ketone increased the activity. The metal chelators EDTA (5 mM) and o-phenanthroline (1 mM) strongly enhanced the activity. Benzamidine and p-aminobenzamidine at 5 mM inhibited the activity. The effects of bivalent cations added at a concentration of 0.5 mM were also examined. The activity of protease VII was not affected by MnCl2, CaCl2, or MgSO4, inhibited by 32% with CoCl2, and significantly inhibited by ZnC12, CuCl2, and FeSO4. Substrate specificity of protease VII. The ability of protease VII to hydrolyze small synthetic substrates was tested. The substrates for trypsin (Bz-Arg-MCA [see Table 2 ]) and for chymotrypsin (Suc-Leu-Leu-Val-Tyr-MCA and Suc-Ala-Ala-Pro-Phe-MCA) and all other MCA substrates examined were not cleaved by protease VII ( Table 2) . These results strongly suggest that protease VII is distinct from trypsinlike and chymotrypsinlike proteases.
The nature of the sites cleaved by protease VII was determined by using several biologically active peptides. Digested peptides were separated by reverse-phase HPLC, and their amino acid compositions were determined as described in Materials and Methods. Table 2 shows the site(s) at which peptides were cleaved by protease VII. Insulin B chain, commonly used as a substrate for investigating the substrate specificity of proteases, was not cleaved at all. Dynorphin A, which had been shown to be a good substrate for protease VII (39) , was cleaved only at Arg-6-Arg-7. Mastoparan was cleaved at Lys-11-Lys-12, and aneo-endorphin was cleaved at Arg-6-Lys-7. Parathyroid hormone (human, 13-34) was cleaved at both Arg-25-Lys-26 and Lys-26-Lys-27. On the other hand, the digested peptides of parathyroid hormone which have Arg-Lys or Lys-Lys at their C terminus or N terminus, respectively, were not cleaved any further by protease VII (data not shown). These results indicate that protease VII is an endopeptidase which specifically recognizes and cleaves consecutive basic residues.
Amino acid sequence of the N-terminal region of protease VII. The N-terminal amino acid sequence analyses of protease VII were carried out by automated Edman degradation with a gas-phase sequencer (Applied Biosystems) as described in Materials and Methods. The sequence determined was Ser-1-Thr-Glu-Thr-Leu-Ser-Phe-Thr-Pro-Asp-10-Asn-Ile-Asn-Ala-Asp-Ile-Ser-Leu-Gly-Thr-20, which is apparently different from the signal peptide sequences.
Cloning and complete nucleotide sequence of protease VII. Cloning of the protease VII gene was performed by complementation analysis of the protease VII-negative mutation as Tyr-Gly-Gly-Phe-Leu-Arg*'Arg-Ile-Arg-Pro-Lys-Leu-Lys Mastoparan Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys!Lys-Ile-Leu a-Neo-endorphin Tyr-Gly-Gly-Phe-Leu-Arg*Lys-Tyr-Pro-Lys Parathyroid hormone Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg*Lyst-Lys-Leu-Gln-Asp-Val-
His-Asn-Phe C terminus of human gamma interferon
Gly-Lys*Arg-Lys-Arg-Ser-Gln-Met-Leu-Phe-Arg-Gly-Arg*Arg-Ala-Ser-Gln described previously (38) . The restriction map of the 1.75kbp insert in pGP501 and the sequencing strategy are presented in Fig. 3A . One major ORF of significant length extending from residues 451 to 1401, corresponding to 317 codons, was identified (Fig. 3B ). This ORF should represent the protease VII gene, since it extended beyond the HincIl site previously shown to be located in the protease VII structural gene (38) . The initiator codon, ATG, for this ORF was preceded by a probable Shine-Dalgarno sequence (37), GGAGAA, 6 to 11 nucleotides upstream. The stop codon at the end of the protease VII gene was TAA.
Examination of the protein encoded by the ORF showed that amino acids 21 to 40 were identical to the N-terminal 20 residues of purified protease VII. This result indicates that the ORFis the structural gene of pre-protease VII and that a signal peptide of 20 amino acids is cleaved in the maturation process. The existence of a signal peptide for protease VII was expected from the results of minicell experiments (38) and the outer membrane location of protease VII (39) .
The amino acid sequence of protease VII, as deduced from the identified ORF, allowed us to determine the molecular weight of the corresponding protein to be 33,458. This value was nearly consistent with that obtained in a study of expression of the cloned gene in minicells (38) and that for purified protease VII. Protease VII does not have cysteine residues and is relatively rich in hydrophobic amino acids. A plot of the hydropathic nature of pre-protease VII was made by the method of Kyte and Doolittle (20) and is shown in Fig. 4 . The signal sequence was quite hydrophobic and conformed to those observed for other membrane or secreted proteins. Three hydrophobic regions at amino acids 36 to 41, 71 to 76, and 80 to 94 ( Fig. 4) , although relatively short, may serve as a membrane anchor to facilitate the association of protease VII with the outer membrane.
Promoter region of the protease VII gene. There seemed to be two likely arrangements of the -35 and -10 conserved sequences for the promoter region upstream of the coding sequence for protease VII. These were as follows. Consensus: -35, TTGACA; -10, TATAAT; observed 1; -35, TTGACT (384 to 389); -10, TATAAA (402 to 407); observed 2; -35, TTGTGA (331 to 336); -10, TATAAA (360 to 365). Furthermore, the stacking region of 8 nucleotides existed shortly before the Shine-Dalgarno sequence (37) , and it may control the expression of protease VII.
Comparison with other membrane proteins and proteases. We compared the nucleotide sequence and the deduced amino acid sequence of protease VII with those of other known membrane proteins and proteases. Protease VII showed no significant similarity with OmpA, OmpC, OmpF, or PhoE. However, the nucleotide sequence of the protease VII gene was identical with that of ompT recently deter-mined by Grodberg et al. (13) . The coding region was completely identical, and there were a few differences in flanking regions, which might reflect the difference in their origin.
Interestingly, the amino acid sequence of protease VII also showed strong similarity with that of the E protein from Salmonella typhimurium (Fig. 5 ). E protein was identified as an additional ORF of the cloned pgtA gene (44) , but its enzymatic activity and physiological role have not been identified. E protein may not be an outer membrane protein but a cytoplasmic protein, as it does not have signallike sequence at its N terminus. However, the two proteins may have a common ancestral protein.
DISCUSSION
The outer membrane-associated protease called protease VII (39) has been purified to homogeneity from E. coli, and the nucleotide sequence analysis has revealed that protease VII and OmpT are identical. Purification and detailed characterization of this enzyme, first reported in this paper, showed that it is not a trypsinlike protease but a serine endopeptidase having unique substrate specificity for paired basic residues.
Protease VII is expressed as a pre-protease VII, and the signal sequence of 20 amino acids is removed to make a mature form having a molecular weight of 33,458, similar to the value obtained by SDS-PAGE analysis. However, a value of about 180,000 was obtained by TSK-G3000SW gel filtration analysis. It might take a pentameric form; however, it is also possible that an increase in the apparent size of the protein from its interaction with detergent might have occurred, as has been demonstrated for other hydrophobic membrane proteins (15) .
The activity of the purified protease VII was completely inhibited by preincubation with an excess of DFP, suggesting that the enzyme contains a reactive serine in its active site. The insensitivity of the crude enzyme to DFP (16, 34) might be explained by the presence in the outer membrane preparation of some molecules which prevented interaction of the enzyme with DFP. The amino acid sequence deduced from the nucleotide sequence revealed that there was no consensus active-site sequence like that of the trypsinlike serine protease, GDSGG, or the subtilisinlike serine protease, GTSMA. Because protease VII has unique substrate specificity, it would be very interesting to know the active site and the mechanism of cleavage. More studies, such as chemical modification of the purified protease and sitespecific mutation of the gene, are needed to answer those questions.
Protease VII is characterized by its unusual ability to hydrolyze proteins and peptides between paired basic residues. It is distinct from trypsinlike protease because it does not attack solitary basic amino acids. Additionally, a paired basic residue at the N terminus or C terminus was not cleaved by protease VII, suggesting that the enzyme is not an exopeptidase but an endopeptidase. From quantitative analysis of the degradation products of parathyroid hormone by protease VII, we found that the molar concentration of peptides formed by the cleavage at Arg-25-Lys-26 was about twofold higher than that at Lsy-26-Lys-27 (data not shown). This result suggests that the Arg-Lys bond is more susceptible to protease VII than the Lys-Lys bond. As for recombinant human gamma interferon, we showed previously that the Arg-Arg bond was cleaved first and that the Lys-Arg bond was more susceptible than the Arg-Lys bond (39) . However, it is too early to assign an order of susceptibility of paired basic residues to protease VII because the conformation of substrate proteins or peptides affects the activity of proteases.
The inhibitor profile and the substrate specificity of protease VII are entirely different from those of proteases IV and V (32) . Additionally, protease VI, which was identified as a membrane-associated serine protease by Palmer and St. John (33), may not be identical with protease VII, because protease VII was strongly inhibited by Zn2+ but protease VI is not.
It is very interesting that Salmonella typhimurium contains a protein having strong similarity to protease VII. The two proteins may be derived from a common ancestral protein. Although the enzymatic activity and physiological role of E protein have not been identified, it might have similar proteolytic activity. However, the physiological role may not be identical, because E protein may exist in the cytoplasmic space.
Similar enzymes which attack paired basic residues have been reported for Saccharomyces cerevisiae (19, 26, 27) and other eucaryotic cells (34) . These enzymes are reported to be involved in the essential function of propheromone or prohormone processing. The strict substrate specificity of protease VII for paired basic residues indicated that protease VII may have similar functions in E. coli cells. Further investigation is needed to clarify the biological significance of this protease.
